ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

NEXI Company Profile and Key Details

OTC : NEXI

NexImmune, Inc.

$0.00

3.0000000015651188e-120.00%

Open: 4:00 PM

63.52

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

NexImmune, Inc. (NEXI) stock surged 0.00%, trading at $0.00 on OTC, up from the previous close of $0.00. The stock opened at $0.00, fluctuating between $0.00 and $0.00 in the recent session.

Stock Snapshot

0.000099999997

Prev. Close

Open

139

Market Cap

1.39M

Number of Shares

0.0001

Day Low

0.0001

Day High

N/A

P/E Ratio

84.49%

Free Float in %

-18.51

EPS (TTM)

3.29

Book Value

-29.52

Cash Flow per Share

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 17, 2025	0.00	0.00	0.00	0.00	12
Apr 11, 2025	0.00	0.00	0.00	0.00	2
Apr 10, 2025	0.00	0.00	0.00	0.00	10
Apr 08, 2025	0.00	0.00	0.00	0.00	6
Apr 07, 2025	0.00	0.00	0.00	0.00	20
Apr 04, 2025	0.00	0.00	0.00	0.00	60
Mar 27, 2025	0.00	0.00	0.00	0.00	300
Mar 26, 2025	0.00	0.00	0.00	0.00	300
Mar 25, 2025	0.00	0.00	0.00	0.00	300
Mar 24, 2025	0.00	0.00	0.00	0.00	300
Mar 21, 2025	0.00	0.00	0.00	0.00	0
Mar 19, 2025	0.00	0.00	0.00	0.00	300
Mar 17, 2025	0.00	0.00	0.00	0.00	300
Mar 14, 2025	0.00	0.00	0.00	0.00	0
Mar 11, 2025	0.00	0.00	0.00	0.00	300
Mar 07, 2025	0.00	0.00	0.00	0.00	0
Mar 06, 2025	0.00	0.00	0.00	0.00	256
Mar 04, 2025	0.00	0.00	0.00	0.00	483
Mar 03, 2025	0.00	0.00	0.00	0.00	381
Feb 28, 2025	0.00	0.00	0.00	0.00	13.59K

Contact Details

Gaithersburg, MD 20877

United States

Website: https://www.neximmune.comContact: 301 825 9810

About Company

NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; NEXI-002, an autologous cell therapy that is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma; and NEXI-003, a candidate targeted against HPV-associated malignancies, which is in preclinical stage. NexImmune, Inc. was incorporated in 2011 and is headquartered in Gaithersburg, Maryland.

Frequently Asked Questions

What is the current NexImmune, Inc. (NEXI) stock price?

NexImmune, Inc. (OTC: NEXI) stock price is $0.00 in the last trading session. During the trading session, NEXI stock reached the peak price of $0.00 while $0.00 was the lowest point it dropped to. The percentage change in NEXI stock occurred in the recent session was 0% while the dollar amount for the price change in NEXI stock was $0.00.

NEXI's industry and sector of operation?

The OTC listed NEXI is part of Biotechnology industry that operates in the broader Healthcare sector. NexImmune, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of NEXI?

Ms. Kristi Jones R.Ph.
Chief Executive Officer, Pres & Director
Mr. John Trainer M.B.A.
Chief Financial Officer
Dr. Jeffrey S. Weber M.D., Ph.D.
Chief Scientific Advisor, Co-Chairman of Scientific Advisory Board and Member of AI & ID SAB
Mr. Karen Haslbeck
Head of HR
Dr. Robert Douglas Knight M.D.
Chief Medical Officer
Dr. Daniel P. Bednarik
Senior Vice President of Molecular Engineering & Protein Design
Dr. Jerome Bernard Zeldis M.D., Ph.D.
Consultant
Dr. Jack A. Ragheb M.D., Ph.D.
Senior Vice President of Translational Science
Mr. Chad Rubin
Senior Vice President of Corporation Affairs
Dr. Mathias Oelke Ph.D.
Chief Scientific Officer
Mr. Matthew Schiller
Head of Bus. Devel.

How NEXI did perform over past 52-week?

NEXI's closing price is 0% higher than its 52-week low of $0.00 where as its distance from 52-week high of $7.05 is -100%.

How many employees does NEXI have?

Number of NEXI employees currently stands at 6.

Link for NEXI official website?

Official Website of NEXI is: https://www.neximmune.com

How do I contact NEXI?

NEXI could be contacted at phone 301 825 9810 and can also be accessed through its website. NEXI operates from 9119 Gaither Road, Gaithersburg, MD 20877, United States.

How many shares of NEXI are traded daily?

NEXI stock volume for the day was 12 shares. The average number of NEXI shares traded daily for last 3 months was 356.

What is the market cap of NEXI currently?

The market value of NEXI currently stands at $139.00 with its latest stock price at $0.00 and 1.39M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

News

Investing Crypto Market Business US Stocks

Useful Links

Screener Market Data Insider Transactions Upgrades & Downgrades 52 Week Highs & Lows Unusual Volume Dividend Calendar Earnings Calendar

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	6
Beta	2.02
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology